Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Recruiting · NCT07325864 · Observational (researchers observe without assigning treatment)

What this trial is about

investigate the molecular differences between primitive lung cancer and the metastatic site.

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not specified

Study type

Observational (researchers observe without assigning treatment)

patients aged ≥18 years fit enough to tolerate the surgical operation;
the operative risk is considered low based on respiratory reserve and cardiac assessment;
the patient has clearly expressed willingness to adhere;
availability of pathological material for tumor DNA extraction and NGS execution.

Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
Recent or ongoing severe or clinically significant infection.

1 location listed.